Scarica l'app Stockscreener
1.70
6.08%
-0.11
Dopo l'orario di chiusura:
1.70
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SANA Giù?
Forum
Previsione
Precedente Chiudi:
$1.81
Aprire:
$1.81
Volume 24 ore:
2.15M
Relative Volume:
0.45
Capitalizzazione di mercato:
$382.54M
Reddito:
-
Utile/perdita netta:
$-283.26M
Rapporto P/E:
-1.1565
EPS:
-1.47
Flusso di cassa netto:
$-273.61M
1 W Prestazione:
+26.87%
1M Prestazione:
-41.98%
6M Prestazione:
-58.94%
1 anno Prestazione:
-80.12%
Intervallo 1D:
$1.655
$1.92
Intervallo di 1 settimana:
$1.32
$1.92
Portata 52W:
$1.26
$10.50
Sana Biotechnology Inc Stock (SANA) Company Profile
Nome
Sana Biotechnology Inc
Settore
Industria
Telefono
(206) 701-7914
Indirizzo
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Confronta SANA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
1.70 | 382.54M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.49 | 128.67B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.91 | 60.99B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
605.38 | 36.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
230.93 | 29.89B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.84 | 25.73B | 3.81B | -644.79M | -669.77M | -6.24 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-18 | Aggiornamento | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | Iniziato | Jefferies | Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-11-05 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | Iniziato | Rodman & Renshaw | Buy |
| 2024-01-16 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-05 | Iniziato | Citigroup | Buy |
| 2023-08-14 | Iniziato | TD Cowen | Market Perform |
| 2023-05-02 | Iniziato | H.C. Wainwright | Neutral |
| 2021-03-01 | Iniziato | BofA Securities | Buy |
| 2021-03-01 | Iniziato | Goldman | Neutral |
| 2021-03-01 | Iniziato | JP Morgan | Neutral |
| 2021-03-01 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Sana Biotechnology Inc Borsa (SANA) Ultime notizie
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure - Bluefield Daily Telegraph
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA - TradingView
Investors in Sana Biotechnology, Inc. Should Contact The Gross Law Firm Before May 20, 2025 to - Bluefield Daily Telegraph
Investors in Sana Biotechnology, Inc. Should Contact The - GlobeNewswire
Press Release Distribution & PR Platform - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain OfficersSANA - PR Newswire
Levi & Korsinsky Notifies Shareholders of Sana Biotechnology, Inc.(SANA) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus
Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - ACCESS Newswire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit - Eastern Progress
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit - Bluefield Daily Telegraph
SANA Investors Have the Opportunity to Lead the Sana - GlobeNewswire
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar
KLP Kapitalforvaltning AS Takes Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. LawsuitSANA - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure - Bluefield Daily Telegraph
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA - TradingView
Class Action Filed Against Sana Biotechnology, Inc. (SANA) Seeking Recovery for InvestorsContact Levi & Korsinsky - PR Newswire
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives $10.80 Average PT from Brokerages - Defense World
Sana Biotechnology, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationSANA - ACCESS Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. LawsuitSANA - MarketScreener
Shareholders of Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your RightsSANA - ACCESS Newswire
ROSEN, A LEADING AND RANKED FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure - Bluefield Daily Telegraph
ROSEN, A LEADING AND RANKED FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA - TradingView
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class - GlobeNewswire
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Suit Seeking Recovery – ... - Bluefield Daily Telegraph
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - Morningstar
Lawsuit filed for Investors who lost money with shares of Sana Biotechnology, Inc. (NASDAQ: SANA) - openPR.com
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - markets.businessinsider.com
Robbins LLP Sues Sana Biotechnology for Misleading Investors - Lawyer Monthly
SANA Stockholders Should Contact Shareholder Rights Law Firm Robbins LLP for Information on How to Lead the Class Action Against Sana Biotechnology, Inc. - GlobeNewswire
Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors - GlobeNewswire
Shareholders of Sana Biotechnology, Inc. Should Contact The Gross Law Firm Before May 20, 2025 to Discuss Your RightsSANA - Finansavisen
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
SANA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sana Biotechnology, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
Sana Biotechnology, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your RightsSANA - ACCESS Newswire
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the - GlobeNewswire
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit ... - Bluefield Daily Telegraph
Shareholders of Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights – SANA - ACCESS Newswire
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure - Bluefield Daily Telegraph
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Sana - GlobeNewswire
SANA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sana Biotechnology, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
Robbins LLP Reminds SANA Investors with Large Losses to Contact the Firm for Information About the Securities Fraud Class Action Against Sana Biotechnology, Inc. - Finansavisen
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sana - GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - GlobeNewswire
Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday - Benzinga
Sana Biotechnology Inc (NASDAQ: SANA) Drops -10.71%, Turning Investors Away - stocksregister.com
Sana Biotechnology Inc Azioni (SANA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.98%
5.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):